Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 10.15M | 19.2% | $ 52.86M |
3/31/2025 | $ 10.27M | 22.54% | $ 45.57M |
12/31/2024 | $ 10.29M | 17.77% | $ 57.88M |
9/30/2024 | $ 10.19M | 23.64% | $ 43.09M |
6/30/2024 | $ 9.87M | 21.47% | $ 45.97M |
3/31/2024 | $ 9.44M | 17.94% | $ 52.6M |
12/31/2023 | $ 8.98M | 24.74% | $ 36.27M |
9/30/2023 | $ 8.54M | 16.5% | $ 51.77M |
6/30/2023 | $ 8.2M | 15.46% | $ 53.04M |
3/31/2023 | $ 7.87M | 14.71% | $ 53.48M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor / Revenues
(=) DepAmor %
DepAmor % for INTELLIA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 6.29M ] / Revenues [ $ 62.34M ]
(=) DepAmor % [ 10.09% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.32K |
---|---|
min | -6.41% |
max | 22.52% |
average | 5.85% |
median | 4.2% |
std | 5.13% |